William B. Stilley III - 30 Dec 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ William B. Stilley, III
Issuer symbol
ADIL
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
03 Jan 2023, 05:02:37 UTC
Previous filing
23 Aug 2022
Next filing
25 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Disposed to Issuer $0 -166,667 -14% $0.000000 1,020,979 30 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.